Pneumonia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
SKU : PH1406
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Pneumonia Therapeutics Market growth?
Global Pneumonia Therapeutics Market is expected to reach at a CAGR of 7.5% during the forecast period 2024-2031.
Who are the key players in Pneumonia Therapeutics Market?
Key players are Pfizer Inc., Dr. Reddy's Laboratories, LGM Pharma LLC, Teva Pharmaceuticals Ltd., AdvaCare Pharma, Baxter International Inc., Innoviva Specialty Therapeutics Inc., F. Hoffmann-La Roche Ltd, Sanofi S.A and Lupin Limited.
Related Reports
pharmaceuticalsBreathing Disorder Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 29
Starting from
$4350
pharmaceuticalsPneumoconiosis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsInterstitial lung disease (ILD) Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 28
Starting from
$4350
pharmaceuticalsPulmonary Edema Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350
pharmaceuticalsPneumothorax Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 28
Starting from
$4350
pharmaceuticalsBronchitis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 27
Starting from
$4350